logo

GTBP

GT Biopharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
4.03 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of GTBP
  • Based on a composite score of 4.03/10, we rate GTBP as a Netural. Our analysis breaks down into 3.23/10 for Fundamentals, 1.31/10 for Technicals, and 7.54/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is GTBP undervalued or overvalued?
Technical Analysis of GTBP?
Is money flowing into or out of GTBP?